The main goal in the trial was to determine if Anastrozole could prolong the duration of “condition-absolutely free survival” for that collaborating sufferers. Ailment-absolutely free survival is defined as being the period following prescription drugs and/or therapies are stopped ahead of the individual’s cancer returns. In the course of the